Cited by 259Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchPancreatic function and diabetes

Evaluation of insulin sensitivity in clinical practice and in research settings

Monzillo, Lais U., Hamdy, Osama·2003·Nutrition Reviews

Abstract

Insulin resistance is the core metabolic abnormality in type 2 diabetes. Its high prevalence and its association with dyslipidemia, hypertension, hyperinsulinemia, and high coronary and cerebrovascular mortality put it in the forefront as the plausible target for aggressive intervention. Measurements of insulin sensitivity provide clinicians and clinical researchers with invaluable instruments to objectively evaluate the efficiency of both current and potentially useful interventional tools. Although several methods had been developed and validated to evaluate insulin sensitivity, none of these methods can be universally used in all patients. Nonetheless, a method suitable for use in clinical or basic research may not necessarily be a practical method for use in clinical practice or for epidemiologic research. We reviewed the currently used methods for assessment of insulin sensitivity. For each method, we summarized its procedure, normal value, cut-off value for defining insulin resistance, advantages and limitations, validity, accuracy for each patient population, and suitability for use in clinical practice and in research settings. The methods reviewed include fasting plasma insulin, homeostatic model assessment, quantitative insulin sensitivity check index, glucose-to-insulin ratio, continuous infusion of glucose with model assessment, indices based on oral glucose tolerance test, insulin tolerance test, and the so called "gold standard" methods, the hyperinsulinemic euglycemic clamp and the frequently sampled-intravenous glucose tolerance test.

Integrity signals

Registry

Crossref · 10.1301/nr.2003.dec.397-412

Cites

112 of 112 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Indirect estimates of insulin resistance, such as HOMA-IR and QUICKI, are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.

    “ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”

Cites

1 retracted

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Monzillo, L. U., & Hamdy, O.
Affiliations
Joslin Diabetes Center (US)
Venue
Nutrition Reviews
Published
2003-12-01
Volume
61
Issue
12
Pages
397-412
ISSN
  • 0029-6643 (ISSN-L)
  • 1753-4887
OpenAlex
W1967727920
Cited by
259
References
112
Citations by year
2026: 1 · 2025: 6 · 2024: 13 · 2023: 5 · 2022: 11 · 2021: 9 · 2020: 11 · 2019: 4 · 2018: 12 · 2017: 10 · 2016: 11 · 2015: 6 · 2014: 22 · 2013: 18 · 2012: 10
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
  • Nutrition Reviews (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Surgery › Pancreatic function and diabetes
Keywords
insulin sensitivity, insulin resistance, type 2 diabetes, HOMA, QUICKI, glucose-to-insulin ratio, hyperinsulinemic-euglycemic clamp, frequently sampled intravenous glucose tolerance test, insulin tolerance test, oral glucose tolerance test, fasting insulin, method validation, research versus clinical practice
MeSH terms
Blood Glucose, Diabetes Mellitus, Diabetes Mellitus, Type 2, Evaluation Studies as Topic, Glucose Tolerance Test, Humans, Hyperlipidemias, Hypertension, Insulin, Insulin Resistance, Obesity, United States, Metabolic Syndrome, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review